Covid-19: Regeneron's antibody combination cuts deaths in seronegative patients, trial finds.BMJ. 2021 Jun 17; 373:n1570.BMJ
Links
Pub Type(s)
Journal Article
Language
eng
PubMed ID
34140312
Citation
Mahase, Elisabeth. "Covid-19: Regeneron's Antibody Combination Cuts Deaths in Seronegative Patients, Trial Finds." BMJ (Clinical Research Ed.), vol. 373, 2021, pp. n1570.
Mahase E. Covid-19: Regeneron's antibody combination cuts deaths in seronegative patients, trial finds. BMJ. 2021;373:n1570.
Mahase, E. (2021). Covid-19: Regeneron's antibody combination cuts deaths in seronegative patients, trial finds. BMJ (Clinical Research Ed.), 373, n1570. https://doi.org/10.1136/bmj.n1570
Mahase E. Covid-19: Regeneron's Antibody Combination Cuts Deaths in Seronegative Patients, Trial Finds. BMJ. 2021 Jun 17;373:n1570. PubMed PMID: 34140312.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Covid-19: Regeneron's antibody combination cuts deaths in seronegative patients, trial finds.
A1 - Mahase,Elisabeth,
Y1 - 2021/06/17/
PY - 2021/6/18/entrez
PY - 2021/6/19/pubmed
PY - 2021/6/19/medline
SP - n1570
EP - n1570
JF - BMJ (Clinical research ed.)
JO - BMJ
VL - 373
SN - 1756-1833
UR - https://www.unboundmedicine.com/medline/citation/34140312/Covid_19:_Regeneron's_antibody_combination_cuts_deaths_in_seronegative_patients_trial_finds_
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
